Clinical Trial Update: Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intranasal oxytocin for emotion recognition and stress-induced cortisol response in central diabetes insipidus patients, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arginine Vasopressin Deficiency
• Central Diabetes Insipidus
• Diabetes Insipidus

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Arginine Vasopressin Deficiency, Diabetes Insipidus | Phase 2 | Status: RECRUITING